Advances in Ultra-Sensitive Genomic Technologies for Cancer and Infectious Disease Diagnostics.

Complete Genomics DNBSEQ™ technology combines high sequencing accuracy with cost efficiency and scalability. Its portfolio of benchtop to high-throughput sequencing platforms supports diverse applications, including ctDNA monitoring and infectious disease diagnostics.
This workshop features leaders in translational genomics demonstrating how DNBSEQ sequencing technology is transforming clinical workflows. Dr. Qin Yan, from Yale University, will present an ultra-sensitive WGS-based ctDNA assay for real-time monitoring of melanoma immunotherapy. Dr. Ravindra Kolhe, from Augusta University, will present a validated 1080-gene CGP panel on the DNBSEQ-T1+, highlighting its reproducibility and rapid reporting capabilities. Dr. Dimitri Gonzalez, from ABL Diagnostics, will showcase a multiplexed infectious disease workflow on DNBSEQ-E25, integrating HIV, bacterial, and fungal testing.
Together, these talks highlight how DNBSEQ enables early detection, precision monitoring, and scalable clinical genomics.